Evaluating outcomes of mother–infant pairs using dolutegravir for HIV treatment during pregnancy

OBJECTIVES: Dolutegravir (DTG), a second-generation integrase inhibitor, is an effective treatment for HIV but its safety and efficacy are not well established in pregnancy. Here, we assess maternal and infant outcomes of mother–infant pairs using DTG-containing regimens during pregnancy. METHODS: W...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AIDS
Hlavní autoři: Grayhack, Clara, Sheth, Anandi, Kirby, Olivia, Davis, Jennifer, Sibliss, Kedesha, Nkwihoreze, Hervette, Aaron, Erika, Alleyne, Gregg, Laguerre, Roberta, Rana, Aadia, Badell, Martina, Momplaisir, Florence
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2018
Témata:
Clinical Science: Concise Communication
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125741/
https://ncbi.nlm.nih.gov/pubmed/29944472
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001931
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky